BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 4, 2000
View Archived Issues
SmithKline Beecham launches Abreva in U.S.; Avanir receives milestone payment
Read More
EMEA recommends approval of Reductil for management of obesity
Read More
ABX-CBL granted orphan drug status for treatment of acute GVHD
Read More
Biological activity of new member of VEGF family confirmed by Collateral Therapeutics
Read More
NXY-059 to enter phase I trials as a potential treatment for acute stroke in Japan
Read More
CAT grants Immunex license related to development of novel human MAbs
Read More
Phase I trial of new treatment for HCV and associated liver cancer cleared in Israel
Read More
BioStratum and Shire collaborate on XR formulation of Pyridorin
Read More
Neuroprotective effects demonstrated in vitro and in vivo for new caspase inhibitor
Read More
Antagonism of neuropeptide Y1 receptors protects against focal cerebral ischemia
Read More
Multiple doses of BMS-204352 safe and well tolerated in acute stroke patients
Read More
Beneficial effects of AM-36 against veratridine-induced neuronal injury suggest potential in stroke
Read More
Proteasome inhibition as a novel approach to stroke: initial clinical results for PS-519
Read More
CDK-inhibitory pyrazolobenzodiazepines for cancer
Read More
New PARP inhibitors presented by BASF for use in neurological, neurodegenerative disorders
Read More
Nelarabine + fludarabine has significant activity, acceptable toxicity in refractory leukemias
Read More
Inhibitors of NHE and their use in cardiovascular disorders claimed by BMS
Read More
Japanese patent covers new steroidal antiproliferative compounds identified at Kaneka
Read More
Carbapenems with good oral bioavailability prepared by Sankyo researchers
Read More
Kyowa Hakko reveals newest inhibitors of PDE5 and their potential therapeutic applications
Read More
Korean researchers discover new series of protein farnesyltransferase inhibitors
Read More
Novel series of tricyclic osteogenesis promoters patented by Taisho
Read More
Preliminary data reported from two Insmed diabetes clinical trials
Read More
Phase I safety and pharmacokinetic analysis of AP-1903 reported at Hematology meeting
Read More
Cubist acquires rights to oral ceftriaxone
Read More
Recombinant urate oxidase is a safe and effective uricolytic agent in hematological malignancies
Read More
Novel Gardos channel inhibitor improves RBC dehydration and sickling in transgenic mouse model
Read More